Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease

NCT01388933 is registered in ClinicalTrials.gov with Tsumura USA as lead sponsor.

NCT NCT01388933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01388933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Lead sponsor
Tsumura USA
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2011
Completion date
September 30, 2013
Enrollment
79 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease